Agilon Health, Inc. (AGL)
115.66
+5.36
(+4.86%)
USD |
NYSE |
Nov 13, 16:00
115.65
-0.01
(-0.01%)
After-Hours: 19:59
Agilon Health Max Drawdown (5Y) : 99.27% for Oct. 31, 2026
Max Drawdown (5Y) Chart
Historical Max Drawdown (5Y) Data
| Date | Value |
|---|---|
| October 31, 2026 | 99.27% |
| September 30, 2026 | 99.27% |
| August 31, 2026 | 99.27% |
| July 31, 2026 | 99.27% |
| June 30, 2026 | 99.27% |
| May 31, 2026 | 99.27% |
| April 30, 2026 | 99.27% |
| March 31, 2026 | 99.27% |
| February 28, 2026 | 99.18% |
| Date | Value |
|---|---|
| January 31, 2026 | 98.81% |
| December 31, 2025 | 98.81% |
| November 30, 2025 | 98.81% |
| October 31, 2025 | 98.16% |
| September 30, 2025 | 98.00% |
| August 31, 2025 | 98.00% |
| July 31, 2025 | 96.37% |
| June 30, 2025 | 96.37% |
| May 31, 2025 | 96.37% |
Max Drawdown Definition
Max drawdown is an indicator of the risk of a portfolio chosen based on a certain strategy. It measures the largest single drop from peak to bottom in the value of a portfolio before a new peak is achieved.
Max Drawdown (5Y) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Max Drawdown (5Y) Benchmarks
| Astrana Health, Inc. | 84.80% |
| Starling Oncology, Inc. | 98.83% |
| Nakamoto, Inc. | -- |
| American Oncology Network, Inc. | 100.00% |
| Biodesix, Inc. | 99.30% |
Max Drawdown (5Y) Related Metrics
| Alpha (5Y) | -61.95 |
| Beta (5Y) | 3.100 |
| Annualized Standard Deviation of Monthly Returns (5Y Lookback) | 144.7% |
| Historical Sharpe Ratio (5Y) | -0.2523 |
| Historical Sortino (5Y) | -0.704 |
| Monthly Value at Risk (VaR) 5% (5Y Lookback) | 43.08% |